EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Variation in neutrophil levels and artemisinin-based combination therapy efficacy in West-Africa

Moussa Djimde, Kassoum Kayentao, Japhet Kabalu Tshiongo, Bakary Fofana, Charles Arama, Sodiomon B Sirima, Jean Bosco Ouedraogo, Abdoul Habib Beavogui, Issaka Sagara, Alassane Dicko, Petra F Mens, Henk Dfh Schallig und 1 weitere

The Journal of Infection in Developing Countries · 2023

DOI: 10.3855/jidc.17089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2023. Verfasst von Moussa Djimde und 12 weiteren Autor:innen. Beteiligte Einrichtung: Malaria Research and Training Center (MRTC), University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Falciparum, Artemisinins, Malaria. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European and Developing Countries Clinical Trials Partnership.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Polymorphonuclear neutrophils (PMN) are involved in pathogen clearance by phagocytosis. However, the role of PMNs in the efficacy of artemisinin-based combination therapy (ACT) is poorly understood. Methodology: In a prospective longitudinal in vivo study, neutrophil rates were compared with malaria carriage after treatment with different ACTs: Artemether - lumefantrine (AL), Artesunate - amodiaquine (ASAQ), Dihydroartemisinin - piperaquine (DP) or Pyronaridine artesunate (PA). The study cases were classified as having neutropenia, normal neutrophil levels or neutrophilia depending on the level of neutrophils in the blood. This study included 3148 patients and was analyzed using R.

Results

On day 7, only four patients in the neutropenia group and treated with AL had a malaria positive blood smear based on microscopy. On day 28, the rate of recurrent parasitemia in the AL arm was significantly higher in neutropenia patients (50.9%) than in patients with normal rates of neutrophils (43.1%) or in those with neutrophilia (6.0%) (p < 0.001). In ASAQ arm, the rate of recurrent Plasmodium falciparum parasitemia was 58.8% in the neutropenia group versus 29.4% in patients with normal rates of neutrophils and 11.8% in patients with neutrophilia (p < 0.001). No patient treated with DP with normal neutrophil counts or neutrophilia was carrying malaria parasites on day 28. Among the 15 patients with parasitemia on day 28 in the PA arm, 11 (73.33%) had neutropenia while 4 (26.67%) had a normal neutrophil count (p < 0.001).

Conclusions

Patients with neutropenia had higher rates of recurrent P. falciparum parasitemia after ACT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsMalaria, FalciparumArtemisininsMalariaNeutropeniaHumansArtesunateNeutrophilsParasitemiaProspective StudiesArtemether, Lumefantrine Drug CombinationAmodiaquineDrug CombinationsAfricaPlasmodium falciparumEthanolamines

Stichwörter der Autor:innen

West Africaartemisinin-based combination therapymalarianeutrophils

Substanzen

ArtesunateAntimalarialsArtemether, Lumefantrine Drug CombinationAmodiaquineartenimolArtemisininsDrug CombinationsEthanolamines

Autor:innen und Institutionen

  • Malaria Research and Training Center (MRTC), University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali.
  • Department of Tropical Medicine, University of Kinshasa (UNIKIN), Kinshasa, Democratic Republic of the Congo.
  • Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
  • Institut des Sciences et des Techniques Bobo Dioulasso (INSTech-Bobo), Burkina Faso.
  • Centre National de Formation et de Recherche en Santé Rurale (CNFRSR), Mafinrinha, Guinea.
  • Amsterdam University Medical Centre, Academic Medical Centre at the University of Amsterdam (AMC), Amsterdam, The Netherlands.

Förderung

  • European and Developing Countries Clinical Trials Partnership

Zitieren

APA

Djimde, M., Kayentao, K., Tshiongo, J. K., Fofana, B., Arama, C., Sirima, S. B., Ouedraogo, J. B., Beavogui, A. H., Sagara, I., Dicko, A., Mens, P. F., Schallig, H. D., & Djimde, A. (2023). Variation in neutrophil levels and artemisinin-based combination therapy efficacy in West-Africa. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.17089

Vancouver

Djimde M, Kayentao K, Tshiongo JK, Fofana B, Arama C, Sirima SB, et al. Variation in neutrophil levels and artemisinin-based combination therapy efficacy in West-Africa. The Journal of Infection in Developing Countries. 2023. doi:10.3855/jidc.17089

BibTeX
@article{Djimde2023,
  author = {Djimde, Moussa and Kayentao, Kassoum and Tshiongo, Japhet Kabalu and Fofana, Bakary and Arama, Charles and Sirima, Sodiomon B and Ouedraogo, Jean Bosco and Beavogui, Abdoul Habib and Sagara, Issaka and Dicko, Alassane and Mens, Petra F and Schallig, Henk Dfh and Djimde, Abdoulaye},
  title = {Variation in neutrophil levels and artemisinin-based combination therapy efficacy in West-Africa},
  journal = {The Journal of Infection in Developing Countries},
  year = {2023},
  doi = {10.3855/jidc.17089}
}
Kostenlos starten →